Search - Prime Therapeutics
Navigate to
-
Real-world study of GLP-1 patients continues to deliver leading insights
PA Sub-Categories: GLP-1 Prime Article: Press Releases -
Real-world, integrated data follows-up on previous insights, analytics.
PA Sub-Categories: GLP-1 Prime Article: Press Releases -
Prime to present seven studies and receive the 2024 JMCP Award for Excellence
PA Sub-Categories: GLP-1 Technology Prime Article: Press Releases -
As demand for GLP-1a drugs for weight loss has increased, new data provides additional insights about this new class of medications.
PA Sub-Categories: GLP-1 Prime Article: Press Releases -
Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.
PA Sub-Categories: GLP-1 Specialty drugs Products Prime Article: Press Releases -
Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases -
Identifying and managing diabetes and weight loss therapies earns AMCP platinum award
PA Sub-Categories: GLP-1 Specialty drugs Products Prime Article: Press Releases -
13th annual report the preeminent source for medical benefit drug trend
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
These new solutions reflect Prime's distinctive conflict-free approach to the prescription drug supply chain model.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care
PA Sub-Categories: Specialty drugs Products Prime Article: Press Releases -
Dinesh Kandanchatha joined the organization July 1.
Prime Article: Press Releases -
Identifying the associated medical cost savings with improving medication adherence study earns organization’s platinum award.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases -
Discover the latest trends and emerging strategies to manage rising medical benefit specialty drug spend.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Lowest net cost strategy helps enable provider, patient choice; helps ensure optimal, cost-effective therapy for complex inflammatory conditions.
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
NCQA has awarded Prime Therapeutics LLC certification in Pharmacy Benefits
Prime Article: Press Releases -
Prime’s signature report — with its deep insights and forecasting — recognized in health care industry as credible source to inform payer strategies
PA Sub-Categories: Specialty drugs Prime Article: Press Releases -
Using real-time pricing, Advocate+ Pharmacy Match drives affordability for plan sponsors while offering access to the most competitive pharmacy for each member.
PA Sub-Categories: Specialty drugs Products Prime Article: Press Releases -
New holistic care program proactively helps members access financial savings options to reduce medication cost, navigates prior authorizations to speed time to therapy
PA Sub-Categories: Specialty drugs Products Prime Article: Press Releases